跳至主要内容
临床试验/NCT07012551
NCT07012551尚未招募不适用

Endovascular Modalites for Contralateral Common Iliac Artery in Patients With Symptomatic Unilateral Common Iliac Artery Occlusive Disease

Assiut University0 个研究点目标入组 50 人开始时间: 2025年8月1日最近更新:

试验速览

阶段
不适用
状态
尚未招募
入组人数
50
主要终点
Primary patency of both common iliac arteries

研究概览

简要总结

To evaluate the safety, efficacy, and outcomes of endovascular strategies for protection of the contralateral CIA in patients with symptomatic unilateral CIA occlusive disease

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Symptomatic patients (Rutherford category 3- 5) due to Unilateral common iliac artery occlusive disease.
  • with or without combined iliac or femoropopliteal or infrapopliteal lesions.
  • Asymptomatic Contralateral limb.
  • Patent at least one run-off vessel

排除标准

  • Distal aorta lesion
  • contralateral CIA occlusion
  • Previous endovascular or surgical procedures for the same lesion
  • Hypersensitivity to contrast material
  • Presence of aortic or iliac aneurysms
  • Patients with unsalvageable limb
  • Non atherosclerotic lesions

结局指标

主要结局

Primary patency of both common iliac arteries

时间窗: 2 years

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Abdelrahman Ahmed Shawki Roshdi

assistant lecturer

Assiut University

相似试验